CD274 and neoplasm: The mechanisms of response and resistance to anti-programmed death 1 (PD-1)/programmed death ligand 1 (PD-L1) drugs, and the biomarkers derived from them, can be grouped into two categories: host-centric (the study of intestinal microbiota, for example), or tumor-centric [4], which is currently the most advanced.